JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.56B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.56B |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.17B |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$777M |
| 5 |
iShares S&P 500 Growth ETF
IVW
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.82B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.38B |
| 3 |
Apple
AAPL
|
+$977M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$915M |
| 5 |
Walt Disney
DIS
|
+$778M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.46% |
| 2 | Technology | 11.62% |
| 3 | Healthcare | 10.99% |
| 4 | Consumer Discretionary | 8.24% |
| 5 | Industrials | 7.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
PUT
Logitech
LOGI
$14.7B
| $2.35M | ﹤0.01% |
75,000
| – | – |
|
3027
ProShares MSCI EAFE Dividend Growers ETF
EFAD
$62.6M
| $2.34M | ﹤0.01% |
70,213
-6,034
| -8% | -$213K |
|
3028
State Street SPDR S&P Emerging Markets Dividend ETF
EDIV
$1.22B
| $2.34M | ﹤0.01% |
78,306
+1,041
| +1% | +$30.8K |
|
3029
United Bankshares
UBSI
$6.63B
| $2.34M | ﹤0.01% |
75,087
+8,300
| +12% | +$280K |
|
|
EPE
3030
DELISTED
EP Energy Corporation
EPE
| $2.33M | ﹤0.01% |
3,330,501
-1,352,626
| -29% | -$2.02M |
|
3031
CALL
PVH
PVH
$4B
| $2.32M | ﹤0.01% |
+25,000
| New | +$2.86M |
|
|
EPZM
3032
DELISTED
Epizyme, Inc
EPZM
| $2.32M | ﹤0.01% |
377,243
+14,400
| +4% | +$110K |
|
3033
AMN Healthcare
AMN
$1.3B
| $2.31M | ﹤0.01% |
40,826
-10,989
| -21% | -$616K |
|
3034
B&G Foods
BGS
$287M
| $2.31M | ﹤0.01% |
79,914
+28,155
| +54% | +$805K |
|
3035
Compañía de Minas Buenaventura
BVN
$7.69B
| $2.31M | ﹤0.01% |
142,413
-117,272
| -45% | -$1.69M |
|
|
CBM
3036
DELISTED
Cambrex Corporation
CBM
| $2.31M | ﹤0.01% |
61,151
-72,804
| -54% | -$3.69M |
|
|
UBNK
3037
DELISTED
United Financial Bancorp, Inc.
UBNK
| $2.31M | ﹤0.01% |
156,960
+7,937
| +5% | +$125K |
|
|
BCPC
3038
Balchem Corp
BCPC
$5.38B
| $2.3M | ﹤0.01% |
29,413
-19,194
| -39% | -$1.73M |
|
3039
Standard BioTools
LAB
$340M
| $2.3M | ﹤0.01% |
267,091
+194,752
| +269% | +$1.52M |
|
3040
Schwab Fundamental US Small Company Index ETF
FNDA
$9.12B
| $2.3M | ﹤0.01% |
139,896
+132,614
| +1,821% | +$2.43M |
|
|
LDL
3041
DELISTED
Lydall, Inc.
LDL
| $2.3M | ﹤0.01% |
113,091
+105,040
| +1,305% | +$2.87M |
|
3042
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.67B
| $2.29M | ﹤0.01% |
76,166
+56,648
| +290% | +$1.73M |
|
|
BLUE
3043
PUT
DELISTED
bluebird bio
BLUE
| $2.29M | ﹤0.01% |
1,783
+1,459
| +450% | +$2.24M |
|
3044
Enova International
ENVA
$6.33B
| $2.29M | ﹤0.01% |
117,802
-186,998
| -61% | -$4.26M |
|
3045
DigitalBridge
DBRG
$2.93B
| $2.29M | ﹤0.01% |
122,192
-492,341
| -80% | -$11.3M |
|
3046
Lifetime Brands
LCUT
$191M
| $2.29M | ﹤0.01% |
227,832
-57,795
| -20% | -$610K |
|
|
FPRX
3047
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $2.28M | ﹤0.01% |
245,575
-12,077
| -5% | -$144K |
|
|
ZAYO
3048
PUT
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $2.28M | ﹤0.01% |
+100,000
| New | +$2.74M |
|
3049
Graham Corp
GHM
$1.12B
| $2.28M | ﹤0.01% |
99,903
+20,208
| +25% | +$500K |
|
|
AIFU
3050
AIFU Inc
AIFU
$206M
| $2.27M | ﹤0.01% |
259
+179
| +224% | +$1.82M |
|
Similar funds
JP Morgan Chase's Q4 2018 Portfolio in Review
As of Q4 2018, JP Morgan Chase held 6,191 positions worth $432B, down 17% from $522B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase withdrew a net $17.1B in Q4 2018, closing 424 positions and reducing 2,219 holdings. Its most notable exit was Energen, an estimated $648M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.
Against the trend, JP Morgan Chase opened a new position in Linde worth $751M.
- JP Morgan Chase's largest Q4 2018 buy was Linde: 4,813,392 shares worth $751M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q4 2018, an estimated $1.56B increase.
- JP Morgan Chase's biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.82B.
- JP Morgan Chase fully exited Energen in Q4 2018, selling an estimated $648M.
- JP Morgan Chase's ten largest holdings make up 16% of its $432B portfolio in Q4 2018.
- JP Morgan Chase opened 487 new positions and closed 424 in Q4 2018.
- JP Morgan Chase's portfolio value fell 17% quarter-over-quarter to $432B.
Based on JP Morgan Chase's 13F filing for Q4 2018, filed 11 Feb 2019.